Efficacy of Using Mobile Health Applications for Health

September 30, 2025 updated by: San Diego State University
The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the same time, and check their blood glucose readings daily before and after meals for at least three meals in the day.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • San Diego, California, United States, 92182
        • Recruiting
        • San Diego State University
        • Contact:
        • Contact:
        • Principal Investigator:
          • Mee Young Hong, PhD
        • Principal Investigator:
          • Robert J Castro, BS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Diagnosed with type II diabetes for at least 3 months
  • Between the age of 18-64
  • BMI ≥ 25
  • Monitors blood glucose regularly (at least once per day)
  • Owns or has access to a bathroom weight scale
  • Owns a smartphone and willing to download mobile app

Exclusion Criteria:

  • Does not check blood glucose at least once per day
  • On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.

Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are oka

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Experimental: Healthi
Other: Mobile health application
Intervention will be with mobile health application

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness of mHealth apps at changing bodyweight assessed by bodyweight measurements over 6 months
Time Frame: 6 months

Determine if mhealth app is an effective weight loss modality compared to standard weight loss program (control)

Outcome measure will be body weight in kg
6 months
Self-efficacy in weight management assessed by Weight Management and Nutrition Knowledge questionnaire
Time Frame: 6 months

Compare and determine which intervention promotes self-efficacy in weight management.

Reporting will be on a scale of 0-100, with higher scores indicating higher self-efficacy
6 months
Long term change in diabetes via A1c
Time Frame: 6 months

Compare and determine which intervention elicits the most change towards diabetes via HbA1c

Outcome measure will be HbA1c
6 months
Long term change in diabetes via fasting blood glucose
Time Frame: 6 months

Compare and determine which intervention elicits the most change towards diabetes via fasting blood glucose

Outcome measure will be fasting blood glucose
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life after using mHealth apps assessed by World Health Organization Quality of Life BREF questionnaire
Time Frame: 6 months

Comparing the two arms to determine which leads to greater quality of life (QOL)

Measures will be reported on a scale of 1-5 across four domains. Scores will be converted to a scale of 0-100
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

San Diego State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Study Registration Dates

First Submitted

October 16, 2022

First Submitted That Met QC Criteria

October 18, 2022

First Posted (Actual)

October 21, 2022

Study Record Updates

Last Update Posted (Estimated)

October 6, 2025

Last Update Submitted That Met QC Criteria

September 30, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HS-2022-0156

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe